The following resources are available for the Provincial Opioid Addiction Treatment Support Program.
PHYSICIANS AND NURSE PRACTITIONERS’ EDUCATION AND TRAINING PATHWAY
Workbooks (physicians and nurse practitioners)
- Community Settings (updated May 2025)
- Acute Care Settings (updated May 2025)
- iOAT (email [email protected] for access)
Preceptorship (physicians and nurse practitioners)
POATSP Online Course
REGISTERED NURSE AND REGISTERED PSYCHIATRIC NURSE OPIOID USE DISORDER CERTIFIED EDUCATION AND TRAINING PATHWAY
Certified Practice Competencies
POATSP: Registered Nurses and Registered Psychiatric Nurses online course
Workbook
- Email [email protected] for the RN/RPN workbook
Preceptorship
- Once a Certificate of Completion is provided from POATSP: RNs and RPNs, the BCCSU will provide information to schedule a preceptorship
Decision Support Tools
- Decision Support Tool for RN and RPN Prescribing of Buprenorphine
- The Sublocade product monograph was updated by Health Canada in December 2025, to reflect the addition of on-label prescribing of alternative injection sites and a rapid induction. While CP-OUD DST revisions are in progress to determine CP-OUD RN/RPN clinical decision-making points in relation to these updates, CP-OUD RNs/RPNs are required to consult with an MD/NP to determine a patient’s clinical suitability for alternative injection sites and/or rapid induction.
- Decision Support Tool for RN and RPN Prescribing of Methadone or Slow-release Oral Morphine
Prescribing
- BCCNM Prescribing standards for registered nurses or registered psychiatric nurses
Resources for all prescribers
Support Line
- 24/7 Addiction Medicine Clinician Support Line: 778-945-7619
Clinical guidance
- For the latest guidance for opioid use disorder, visit the opioid use disorder care guidance page
- For guidance designed to support clinicians as they begin practicing as new OAT prescribers, view the OAT Prescriber Resource Guide
Screening and diagnosis
Medication-specific resources
Buprenorphine/naloxone
- Buprenorphine/naloxone Common Drug–Drug Interactions
- Clinical Opiate Withdrawal Scale (COWS)
- Subjective Opiate Withdrawal Scale (SOWS)
- Traditional Buprenorphine/naloxone Induction: Medications to Minimize Withdrawal Symptoms
- Buprenorphine/naloxone (Suboxone) To Go: Traditional Induction
- Buprenorphine/naloxone (Suboxone) To Go: Low-dose Induction (micro-dosing)
- Buprenorphine/naloxone (Suboxone) To Go: Low-dose Induction (micro-dosing) Wallet-size Dosing Schedule
Methadone
Slow-release oral morphine
All OAT
- Opioid Agonist Treatment Clinics Accepting New Patients
- Opioid Agonist Treatment Pharmacies
- Detection Time of Substances in Urine
British Columbia Substance Use Disorder Community of Practice Inventory

